Mucosal simian immunodeficiency virus transmission in African Green Monkeys: Susceptibility to infection is proportional to target cell availability at mucosal sites

Journal of Virology

Volumn 86, Issue 8, 2012, Pages 4158-4168

  Pandrea, Ivona ^a,b,c   Parrish, Nicholas F ^d,e   Raehtz, Kevin ^b   Gaufin, Thaidra ^a   Barbian, Hannah J ^e   Ma, Dongzhu ^b   Kristoff, Jan ^b   Gautam, Rajeev ^a   Zhong, Fang ^b   Haret Richter, George S ^b   Trichel, Anita ^b   Shaw, George M ^d,e   Hahn, Beatrice H ^d,e   Apetrei, Cristian ^a,b,c  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CHLOROCEBUS; CONTROLLED STUDY; FEMALE; INFECTION SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TARGET CELL; VERTICAL TRANSMISSION; VIRUS CELL INTERACTION; VIRUS TITRATION; VIRUS TRANSMISSION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CERCOPITHECUS AETHIOPS; DISEASE SUSCEPTIBILITY; EVOLUTION, MOLECULAR; FEMALE; MACACA NEMESTRINA; MALE; MUCOUS MEMBRANE; PHYLOGENY; RECEPTORS, CCR5; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL ENVELOPE PROTEINS;

ANIMALIA; CERCOPITHECUS AETHIOPS; MACACA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84861403625     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.07141-11     Document Type: Article

References (81)

1. Bar KJ, et al. 2010. Wide variation in the multiplicity of HIV-1 infection among injection drug users. J. Virol. 84:6241-6247.
2. Barry AP, et al. 2007. Depletion of CD8+ cells in sooty mangabey monkeys naturally infected with simian immunodeficiency virus reveals limited role for immune control of virus replication in a natural host species. J. Immunol. 178:8002-8012.
3. Beaumier CM, et al. 2009. CD4 downregulation by memory CD4+ T cells in vivo renders African green monkeys resistant to progressive SIVagm infection. Nat. Med. 15:879-885.
4. Bibollet-Ruche F, et al. 2004. A new simian immunodeficiency virus lineage (SIVdeb) infecting de Brazza's monkeys (Cercopithecus neglectus): evidence for a Cercopithecus monkey virus clade. J. Virol. 78:7748-7762.
5. Bosinger SE, et al. 2009. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J. Clin. Invest. 119:3556-3572.
6. Brenchley JM, et al. 2008. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112:2826-2835.
7. Brenchley JM, et al. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12:1365-1371.
8. Chahroudi A, et al. 2011. Mother-to-infant transmission of simian immunodeficiency virus is rare in sooty mangabeys and is associated with low viremia. J. Virol. 85:5757-5763.
9. Chakrabarti L, Emerman M, Tiollais P, Sonigo P. 1989. The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity. J. Virol. 63:4395-4403.
10. Chen Z, et al. 1997. Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys. J. Virol. 71:3953-3960.
11. Chenine AL, et al. 2010. Relative transmissibility of an R5 clade C simianhuman immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routes. J. Infect. Dis. 201:1155-1163.
12. Dunham R, et al. 2006. The AIDS-resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus. Blood 108:209-217.
13. Estes JD, et al. 2008. Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques. J. Immunol. 180:6798-6807.
14. Favre D, et al. 2009. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog. 5:e1000295.
15. Fultz PN, Gordon TP, Anderson DC, McClure HM. 1990. Prevalence of natural infection with simian immunodeficiency virus and simian T-cell leukemia virus type I in a breeding colony of sooty mangabey monkeys. AIDS 4:619-625.
16. Gao F, et al. 1999. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397:436-441.
17. Gaufin T, et al. 2009. Limited ability of humoral immune responses in control of viremia during infection with SIVsmmD215 strain. Blood 113: 4250-4261.
18. Gaufin T, et al. 2009. Effect of B cell depletion on viral replication and clinical outcome of SIV infection in a natural host. J. Virol. 83:10347-10357.
19. Gaufin T, et al. 2010. Experimental depletion of CD8+ cells in acutely SIVagm-infected African green monkeys results in increased viral replication. Retrovirology 7:42.
20. Georges-Courbot MC, et al. 1996. Occurrence and frequency of transmission of naturally occurring simian retroviral infections (SIV, STLV, and SRV) at the CIRMF Primate Center, Gabon. J. Med. Primatol. 25:313-326.
21. Gnanadurai CW, et al. 2010. Genetic identity and biological phenotype of a transmitted/founder virus representative of nonpathogenic simian immunodeficiency virus infection in African green monkeys. J. Virol. 84: 12245-12254.
22. Gordon S, et al. 2008. Short-lived infected cells support the bulk of virus replication in naturally SIV-infected sooty mangabeys: implications for AIDS pathogenesis. J. Virol. 82:3725-3735.
23. Gordon SN, et al. 2007. Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. J. Immunol. 179:3026-3034.
24. Grivel JC, et al. 2007. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5-and CXCR4-tropic HIV-1. AIDS 21:1263-1272.
25. Grivel JC, Shattock RJ, Margolis LB. 2011. Selective transmission of R5 HIV-1 variants: where is the gatekeeper? J. Transl. Med. 9:S6.
26. Haase AT. 2005. Perils at mucosal front lines for HIV and SIV and their hosts. Nat. Rev. Immunol. 5:783-792.
27. Haase AT. 2010. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464:217-223.
28. Harris LD, et al. 2010. Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques. J. Virol. 84:7886-7891.
29. Hirsch VM, et al. 1995. Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. J. Virol. 69:955-967.
30. Jacquelin B, et al. 2009. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J. Clin. Invest. 119:3544-3555.
31. Jolly C, Phillips-Conroy JE, Turner TR, Broussard S, Allan JS. 1996. SIVagm incidence over two decades in a natural population of Ethiopian grivet monkeys (Cercopithecus aethiops aethiops). J. Med. Primatol. 25: 78-83.
32. Keele BF, et al. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 105:7552-7557.
33. Keele BF, et al. 2009. Low dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J. Exp. Med. 206:1117-1134.
34. Keele BF, et al. 2006. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 313:523-526.
35. Kornfeld C, et al. 2005. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J. Clin. Invest. 115:1082-1091.
36. Letvin NL, et al. 2007. No evidence for consistent virus-specific immunity in simian immunodeficiency virus-exposed, uninfected rhesus monkeys. J. Virol. 81:12368-12374.
37. Li H, et al. 2010. High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog. 6:e1000890.
38. Li Q, et al. 2009. Glycerol monolaurate prevents mucosal SIV transmission. Nature 458:1034-1038.
39. Liu J, et al. 2010. Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys. J. Virol. 84:10406-10412.
40. Ma ZM, et al. 2009. High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection. J. Virol. 83:3288-3297.
41. Miller CJ, et al. 1994. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J. Virol. 68:6391-6400.
42. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
43. Nerrienet E, et al. 1998. Phylogenetic analysis of SIV and STLV type I in mandrills (Mandrillus sphinx): indications that intracolony transmissions are predominantly the result of male-to-male aggressive contacts. AIDS Res. Hum. Retroviruses 14:785-796.
44. Onanga R, et al. 2002. High levels of viral replication contrast with only transient changes in CD4+ and CD8+ cell numbers during the early phase of experimental infection with simian immunodeficiency virus SIVmnd-1 in Mandrillus sphinx. J. Virol. 76:10256-10263.
45. Onanga R, et al. 2006. Primary simian immunodeficiency virus SIVmnd-2 infection in mandrills (Mandrillus sphinx). J. Virol. 80:3301-3309.
46. Otsyula MG, et al. 1995. Apparent lack of vertical transmission of simian immunodeficiency virus (SIV) in naturally infected African green monkeys, Cercopithecus aethiops. Ann. Trop. Med. Parasitol. 89:573-576.
47. + T cells of SIV-infected sooty mangabeys. Nat. Med. 17:830-836.
48. Pandrea I, et al. 2006. Simian immunodeficiency virus SIVagm.sab infection of Caribbean African green monkeys: a new model for the study of SIV pathogenesis in natural hosts. J. Virol. 80:4858-4867.
49. Pandrea I, et al. 2007. Paucity of CD4+CCR5+T cells is a typical feature of natural SIV hosts. Blood 109:1069-1076.
50. Pandrea I, et al. 2008. Experimentally-induced immune activation in natural hosts of SIV induces significant increases in viral replication and CD4+ T cell depletion. J. Immunol. 181:6687-6691.
51. Pandrea I, et al. 2007. Acute loss of intestinal CD4+ T cells is not predictive of SIV virulence. J. Immunol. 179:3035-3046.
52. Pandrea I, et al. 2005. Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys. J. Virol. 79:6249-6259.
53. Pandrea I, et al. 2003. High levels of SIVmnd-1 replication in chronically infected Mandrillus sphinx. Virology 317:119-127.
54. Pandrea I, et al. 2008. Paucity of CD4+ CCR5+ T cells may prevent transmission of simian immunodeficiency virus in natural nonhuman primate hosts by breastfeeding. J. Virol. 82:5501-5509.
55. Pandrea I, et al. 2008. Simian immunodeficiency virus SIVagm dynamics in African green monkeys. J. Virol. 82:3713-3724.
56. Pandrea I, et al. 2006. Simian immunodeficiency viruses replication dynamics in African non-human primate hosts: common patterns and species-specific differences. J. Med. Primatol. 35:194-201.
57. Pandrea I, Sodora DL, Silvestri G, Apetrei C. 2008. Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts. Trends Immunol. 29:419-428.
58. Phillips-Conroy JE, Jolly CJ, Petros B, Allan JS, Desrosiers RC. 1994. Sexual transmission of SIVagm in wild grivet monkeys. J. Med. Primatol. 23:1-7.
59. Picker LJ, et al. 2004. Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. J. Exp. Med. 200:1299-1314.
60. Pinheiro JC, Bates DM. 2002. Mixed-effects models in S and S-Plus. Springer-Verlag, New York, NY.
61. Plantier JC, et al. 2009. A new human immunodeficiency virus derived from gorillas. Nat. Med. 15:871-872.
62. Sagar M, et al. 2003. Infection with multiple human immunodeficiency virus type 1 variants is associated with faster disease progression. J. Virol. 77:12921-12926.
63. Saitou N, Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
64. Santiago ML, et al. 2005. Simian immunodeficiency virus infection in free-ranging sooty mangabeys (Cercocebus atys atys) from the Tai Forest, Cote d'Ivoire: implications for the origin of epidemic human immunodeficiency virus type 2. J. Virol. 79:12515-12527.
65. Silvestri G, et al. 2005. Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts. J. Virol. 79:4043-4054.
66. Silvestri G, Paiardini M, Pandrea I, Lederman MM, Sodora DL. 2007. Understanding the benign nature of SIV infection in natural hosts. J. Clin. Invest. 117:3148-3154.
67. Silvestri G, et al. 2003. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18:441-452.
68. Simon F, et al. 1998. Identification of a new human immunodeficiency virus type 1 distinct from groupMand group O. Nat. Med. 4:1032-1037.
69. Sodora DL, et al. 2009. Towards an AIDS vaccine: lessons from natural SIV infections of African nonhuman primate hosts. Nat. Med. 15:861-865.
70. Stone M, et al. 2010. A limited number of simian immunodeficiency virus (SIV) env variants are transmitted to rhesus macaques vaginally inoculated with SIVmac251. J. Virol. 84:7083-7095.
71. VandeWoude S, Apetrei C. 2006. Going wild: lessons from Tlymphotropic naturally occurring lentiviruses. Clin. Microbiol. Rev. 19: 728-762.
72. Veazey RS, Marx PA, Lackner AA. 2003. Vaginal CD4+ T cells express high levels of CCR5 and are rapidly depleted in simian immunodeficiency virus infection. J. Infect. Dis. 187:769-776.
73. Veazey RS, et al. 2000. Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activatedmemoryCD4+ Tcells are rapidly eliminated in early SIV infection in vivo. J. Virol. 74:57-64.
74. Wang Z, Metcalf B, Ribeiro RM, McClure H, Kaur A. 2006. Th-1-type cytotoxic CD8+ T-lymphocyte responses to simian immunodeficiency virus (SIV) are a consistent feature of natural SIV infection in sooty mangabeys. J. Virol. 80:2771-2783.
75. Watkins DI, Burton DR, Kallas EG, Moore JP, Koff WC. 2008. Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans. Nat. Med. 14:617-621.
76. Wilks AB, et al. 2011. High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus-infected African green monkeys. J. Virol. 85:9517-9526.
77. Wilson NA, et al. 2009. Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge. J. Virol. 83:6508-6521.
78. Wira CR, Fahey JV. 2008. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 22:1909-1917.
79. Worobey M, et al. 2010. Island biogeography reveals the deep history of SIV. Science 329:1487.
80. Zahn RC, et al. 2008. Simian immunodeficiency virus (SIV)-specific CD8+ T cell responses in chronically SIVagm-infected vervet African green monkeys. J. Virol. 82:11577-11588.
81. Zahn RC, et al. 2010. Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease. Blood 115:3070-3078.